WHO ICTRP trial
Study of Losartan and Standard of care therapy in advanced biliary tract cancer
CTRI/2023/02/049523 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/02/049523 |
|---|---|
| Public title | Study of Losartan and Standard of care therapy in advanced biliary tract cancer |
| Scientific title | Study of losartan and SOC therapy in advanced biliary tract cancer - LAST STUDY |
| Primary sponsor | INHS ASVINI |
| Secondary sponsors | Not applicable |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: C23- Malignant neoplasm of gallbladder |
| Interventions | Intervention1: Tab Losartan Drug: Tab Losartan medication given to all gall bladder carcinoma patient as per inclusion criteria Intervention2: no controlled grou[: not applicable Intervention3: tab Losartan: initially started with with 25mg… |
| Registration date | Jul 2, 2023 |
| Target size | 24 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: